BioStem has developed three perinatal tissue allograft products for wound care — Vendaje®, Vendaje AC®, and Vendaje Optic® — intended for homologous use as a protective covering for soft-tissue wounds. The company says its initial commercial strategy heavily focuses on its products being sold and reimbursed within the Medicare system.
